RA Capital Management portfolio
150 tracked investments, 92 on the map, $6.7B raised across the mapped portfolio.
RA Capital Management150 investments · 92 on the map · $6.7B raised
Janux TherapeuticsSeries B
Arcutis BiotherapeuticsSeries C
Compass PathwaysPost-IPO Equity
Mineralys TherapeuticsPost-IPO Equity
Avalo TherapeuticsPost-IPO Equity
CG OncologySeries F
SynthegoSeries E
Alentis TherapeuticsSeries D
Stoke TherapeuticsSeries B
LENZ THERAPEUTICSPost-IPO Equity
Spyglass PharmaSeries D
CeribellSeries C
Superluminal MedicinesSeries A
Cytek BiosciencesSeries DTORL BioTherapeutics
SynapticureSeries A
ARS Pharmaceuticals OperationsPost-IPO DebtPlexiumSeries B
- KCKadmon, a Sanofi CompanyPost-IPO Equity
- TNTrace NeuroscienceSeries A
- SSynthorxSeries C
- SDSelux DiagnosticsSeries D
Tenaya TherapeuticsPost-IPO Equity
- CPCORXEL PharmaceuticalsSeries D
Ajax TherapeuticsSeries C
Bambusa TherapeuticsSeries A
Forge BiologicsSeries B
VitriVaxSeries B
CorticaSeries D
Capstan TherapeuticsSeries B
RxSightVenture Round
Pyxis OncologySeries B
Zura BioPost-IPO Equity
Vaxess TechnologiesVenture Round
TassoSeries B
Everest MedicinesSeries C
ElektrofiSeries C
Enara BioSeries B
Protara TherapeuticsPost-IPO Equity
Verve TherapeuticsSeries B
Asher BioSeries C
Be BiopharmaSeries C
AmbAgon TherapeuticsSeries A
Azalea TherapeuticsSeed Round
AltruBioSeries B
Xilio TherapeuticsSeries C
Outpace BioSeries B
Pluton BiosciencesSeries A
Avidity BiosciencesPost-IPO Equity
AM BatteriesSeries B
NTxSeries B
Rivus PharmaceuticalsSeries B
Carmot TherapeuticsSeries E
Vesta HealthcareSeries C
Cidara TherapeuticsPost-IPO Equity
AltimmunePost-IPO Equity
Apeiron labsSeries A
Commons ClinicSeries B
AavantiBioSeries A
Mariana OncologySeries B
ArvinasPost-IPO Equity
Genetix Biotherapeutics Inc.Series D
Indapta TherapeuticsVenture Round
Aiolos BioSeries A
NodexusSeries A
SurrozenPost-IPO Equity
Cerebral TherapeuticsSeries C
BraeburnDebt Financing
DTx PharmaSeries B
Bicycle TherapeuticsPost-IPO Equity
SANUWAVE HealthPost-IPO Equity
Werewolf TherapeuticsSeries B
Ovid TherapeuticsPost-IPO Equity
EquilliumPost-IPO Equity
MonoparPost-IPO Equity
CiVi BiopharmaVenture Round
TeraPore TechnologiesVenture Round
Medicenna TherapeuticsPost-IPO Equity
Eledon PharmaceuticalsPost-IPO Equity
FORMA TherapeuticsSeries D
Point BiopharmaPost-IPO Equity
Connect BiopharmaceuticalsSeries C
ITeos TherapeuticsPost-IPO Equity
Eidos TherapeuticsSeries B
Bellicum PharmaceuticalsSeries C
AthersysVenture Round
Johnson & Johnson Innovative MedicineSeed Round
Genelabs TechnologiesVenture Round
ZS PharmaSeries D
Covid Apollo ProjectSeed Round
Intarcia Therapeutics- DPDicerna Pharmaceuticals
Also in the portfolio
- BioAge Labs
- Nimbus Therapeutics
- Triana Biomedicines
- Nautilus Biotechnology
- Terremoto Biosciences
- Aktis Oncology
- Natera
- Acumen Pharmaceuticals
- Design Therapeutics
- Tyra Biosciences
- Halda Therapeutics
- Bristol-Myers Squibb
- TScan Therapeutics
- Stylus Medicine
- Angitia Biopharmaceuticals
- Verdiva Bio
- Exo
- Boundless Bio
- Akari Therapeutics
- Empatica
- NanoMosaic
- Synthekine
- Bia Energy
- Zai Lab
- Edgewise Therapeutics
- ExcepGen
- Sortera Technologies
- Sionna Therapeutics
- Ascendis Pharma
- KalVista Pharmaceuticals
- Abcuro
- Ardelyx
- Prelude Therapeutics
- Adela
- Vivace Therapeutics
- Third Harmonic Bio
- Ventus Therapeutics
- Magenta Medical
- C4 Therapeutics
- Nucleix
- T-knife
- Aurinia Pharmaceuticals
- LianBio
- Iterum Therapeutics
- 89bio
- Sierra Oncology
- Regulus Therapeutics
- Akouos
- Adeo Health Science
- Ra Pharmaceuticals
- Pandion Therapeutics
- Aimmune Therapeutics
- Imara
- Thriveworks
- AmpliPhi Biosciences
Investors similar to RA Capital Management
OrbiMed177 investments · 137 on the map · $9.6B raised
TCG Crossover27 investments · 9 on the map · $4.1B raised
Samsara BioCapital42 investments · 7 on the map · $2.9B raised
Perceptive Advisors109 investments · 13 on the map · $4.4B raised
RTW Investments35 investments · 11 on the map · $2.5B raised
HBM Healthcare Investments56 investments · 10 on the map · $3.4B raised